Rafferty Asset Management
SPRY icon

Rafferty Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History

Rafferty Asset Management’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$945K Buy
117,635
+2,071
+2% +$19.8K ﹤0.01% 785
2025
Q4 		$1.35M Sell
115,564
-6,846
-6% -$66.6K ﹤0.01% 744
2025
Q3 		$1.23M Buy
122,410
+41,564
+51% +$597K ﹤0.01% 747
2025
Q2 		$1.41M Buy
80,846
+5,524
+7% +$79.7K ﹤0.01% 692
2025
Q1 		$948K Sell
75,322
-65,050
-46% -$783K ﹤0.01% 753
2024
Q4 		$1.48M Buy
140,372
+59,097
+73% +$828K 0.01% 716
2024
Q3 		$1.18M Sell
81,275
-4,042
-5% -$48.1K ﹤0.01% 769
2024
Q2 		$726K Sell
85,317
-26,242
-24% -$233K ﹤0.01% 873
2024
Q1 		$1.14M Buy
+111,559
New +$832K ﹤0.01% 810

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return